View Post

HCA Healthcare forms consortium with AHRQ and research institutions to accelerate COVID-19 research

HCA Healthcare is proud to announce that we’ve formed a consortium of prominent public and private research institutions to use HCA Healthcare’s vast data on COVID-19 hospital care to improve patient outcomes and public knowledge. The institutions – including the federal Agency for Health Research and Quality (AHRQ), Johns Hopkins University, Duke University, Meharry Medical…
View Post
View Post

172 HCA Healthcare hospitals join COVID-19 convalescent plasma study

In continuing our efforts to fight the COVID-19 pandemic, HCA Healthcare is taking part in a national study where recovered COVID-19 patients can donate plasma to potentially help critically-ill patients. We are leveraging our clinical research capabilities and national hospital network to improve COVID-19 patient care and outcomes.  Today, we announced that 172 HCA Healthcare…
View Post
View Post

World Cancer Day: we are fighting cancer together

Did you know 1 in 2 men and 1 in 3 women will be diagnosed with cancer in their lifetime? But, there is good news on the horizon. According to the American Cancer Society, new figures are promising, citing a 27% decline in United States cancer death rates since 1991. Sarah Cannon, the Cancer Institute…
View Post
View Post

January is Cervical Cancer Awareness Month: Sarah Cannon shares what you need to know

January is Cervical Cancer Awareness Month, a time to raise awareness around risk factors and treatments for cervical cancer. It is also a time to celebrate that the mortality rate for cervical cancer has dropped by 50% in the past 40 years, which is attributed to the widespread use of Pap smears. “But this doesn’t…
View Post
View Post

Breast cancer breakthrough: Sarah Cannon discusses newly FDA-approved immunotherapy

Spring brings new hope and new beginnings, and for breakthroughs in cancer treatment, this season is off to a promising start. Earlier this month, the U.S. Food and Drug Administration (FDA) approved the first-ever immunotherapy (atezolizumab), in combination with chemotherapy, for the treatment of breast cancer. “Immunotherapy is a drug that we’ve been using in…
View Post